These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 27099524)

  • 1. Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome.
    Marshall-Gradisnik S; Huth T; Chacko A; Johnston S; Smith P; Staines D
    Appl Clin Genet; 2016; 9():39-47. PubMed ID: 27099524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D
    J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Balinas C; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    Mol Med; 2019 Apr; 25(1):14. PubMed ID: 31014226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
    Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Eaton-Fitch N; Du Preez S; Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
    J Transl Med; 2022 Feb; 20(1):94. PubMed ID: 35172836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.
    Nguyen T; Staines D; Nilius B; Smith P; Marshall-Gradisnik S
    Biol Res; 2016 May; 49(1):27. PubMed ID: 27245705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired calcium mobilization in natural killer cells from chronic fatigue syndrome/myalgic encephalomyelitis patients is associated with transient receptor potential melastatin 3 ion channels.
    Nguyen T; Johnston S; Clarke L; Smith P; Staines D; Marshall-Gradisnik S
    Clin Exp Immunol; 2017 Feb; 187(2):284-293. PubMed ID: 27727448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Cabanas H; Muraki K; Staines D; Marshall-Gradisnik S
    Front Immunol; 2019; 10():2545. PubMed ID: 31736966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP
    Eaton-Fitch N; Cabanas H; du Preez S; Staines D; Marshall-Gradisnik S
    J Transl Med; 2021 Jul; 19(1):306. PubMed ID: 34266470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Balinas C; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2019 Dec; 17(1):401. PubMed ID: 31796045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Du Preez S; Eaton-Fitch N; Smith PK; Marshall-Gradisnik S
    Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation into the restoration of TRPM3 ion channel activity in post-COVID-19 condition: a potential pharmacotherapeutic target.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Jeremijenko A; Griffin P; Marshall-Gradisnik S
    Front Immunol; 2024; 15():1264702. PubMed ID: 38765011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A targeted genome association study examining transient receptor potential ion channels, acetylcholine receptors, and adrenergic receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Johnston S; Staines D; Klein A; Marshall-Gradisnik S
    BMC Med Genet; 2016 Nov; 17(1):79. PubMed ID: 27835969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential pathophysiological role of the ion channel TRPM3 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the therapeutic effect of low-dose naltrexone.
    Löhn M; Wirth KJ
    J Transl Med; 2024 Jul; 22(1):630. PubMed ID: 38970055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
    Eaton N; Cabanas H; Balinas C; Klein A; Staines D; Marshall-Gradisnik S
    BMC Pharmacol Toxicol; 2018 Mar; 19(1):12. PubMed ID: 29587879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of Protein Kinase Gene Expression in NK Cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients.
    Chacko A; Staines DR; Johnston SC; Marshall-Gradisnik SM
    Gene Regul Syst Bio; 2016; 10():85-93. PubMed ID: 27594784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP
    Du Preez S; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
    Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34831634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transient receptor potential melastatin 3 proteotypic peptides employing an efficient membrane protein extraction method for natural killer cells.
    Magawa CT; Eaton-Fitch N; Balinas C; Sasso EM; Thapaliya K; Barnden L; Maksoud R; Weigel B; Rudd PA; Herrero LJ; Marshall-Gradisnik S
    Front Physiol; 2022; 13():947723. PubMed ID: 36213251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.